Skip to main content
OpenTrials

Clinical trial condition

Histiocytic Disorders, Malignant

Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.

269 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Histiocytic Disorders, Malignant trial results

Recruiting

A Registry-study of ELZONRIS in Participants With BPDCN

NCT07785154

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Medical University Innsbruck Innsbruck, Austria
  • Ordensklinikum Linz Krankenhaus der Elisabethinen Linz Linz, Austria
  • Salzburg Cancer Research Institute (SCRI) Salzburg, Austria
  • Medizinische Universitat Wien, Department for Internal Medicine I, Division of Hematology and Haemostaseology Vienna, Austria
View all 41 locations
View Trial Details
Recruiting

A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy

NCT07785180

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Odense University Hospital Odense, Denmark
  • Centre Hospitalier Universitaire Besancon Besançon, France
  • Hôpital Avicenne Bobigny, France
View all 67 locations
View Trial Details
Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
  • IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
  • Hospital Beata Maria Ana Madrid, Spain
  • Hospital Fundación Jiménez Diaz Madrid, Spain
View all 17 locations
View Trial Details
Recruiting

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

NCT07121946

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
Locations
  • City of Hope Duarte, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center - Bergen New York, United States
View Trial Details

Related conditions